Asthma & COPD: COVID-19 Myth Busting with Dr. Juanita Mora
We live in the Information Age. Nowadays, however, it can be information overload with an abundance of inaccuracies regularly masquerading as facts. Dr. Juanita Mora, an allergist/immunologist in Chicago, joins us to bust several myths about asthma and COPD management that have been circulating in response to the coronavirus disease (COVID-19). After all, the spread of myths can lead to dangerous decision-making that may affect you and your family.
Stop taking oral, inhaled and/or intranasal corticosteroids due to increased COVID-19 risk since they immunosuppress patients.
Control is the most important thing for your asthma and allergic rhinitis. If you use inhaled corticosteroids, or intranasal steroids, there’s probably not a risk to developing a weakened immune system. If you use oral corticosteroids, there’s a slight increase of a suppressed immune system. If you’re in an asthma flare, your healthcare provider can help you decide which medications are the right choice to help you breathe. Do not stop or avoid taking your medication without discussing with your healthcare provider.
Children with asthma are not at risk because COVID-19 only affects older people.
We must remember that COVID-19 is a respiratory virus. Children and adults with asthma or any other chronic lung disease are at higher risk for complications from COVID-19. Individuals with asthma or other lung diseases are not at higher risk of contracting the virus.
If you have asthma, you should wear a disposable mask when in public areas to help limit COVID-19 exposure.
Masks should be reserved for people who are sick and healthcare workers who are at increased risk of COVID-19 infection. If you have respiratory symptoms (e.g., fever, sneezing, cough, shortness of breath), you should wear a mask to prevent spreading your droplets to others and, as much as possible, stay home.
Smoking and/or vaping does not increase your risk of getting sick with COVID-19?
Cigarette smoking and vaping are linked to lung inflammation and lowered immune function. Both potentially heighten the risk for a more severe response if exposed to COVID-19.
Albuterol or quick relief rescue inhalers can cause the immune system to be suppressed and result in patients with asthma being more susceptible to COVID-19.
These medications are bronchodilators and not corticosteroids. They relax the muscles in your airways when you’re having symptoms. You can and should continue to use your rescue inhaler as needed for asthma symptoms. The most important thing is to have your asthma well-controlled so that if infection does occur, your lungs are better able to handle the virus.
Anti-inflammatory medications (other than inhaled corticosteroids and controller medications) worsen COVID-19 symptoms.
The Food and Drug Administration (FDA) has issued a statement regarding the use of nonsteroidal anti-inflammatory drugs (NSAIDs) for patients with COVID-19. According to the agency, there’s not enough scientific evidence to link the use of NSAIDs to worsening symptoms of COVID-19. Therefore, NSAIDs can still be used even for patients with COVID-19 to treat symptoms, such as fever and muscle aches, if no alternatives seem available. For this reason, if you’re concerned, discuss options with your healthcare provider.
Using nasal sprays may push the COVID-19 virus further up your nose.
Nasal sprays are often used to treat symptoms related to common colds/viruses, including congestion and runny nose. Spring allergy season has begun in many parts of the country – these medications can assist in control of symptoms and, therefore, help prevent asthma flares. Continue to take your prescribed medications and contact your healthcare provider to discuss before discontinuing or avoiding.
Exercise puts patients with asthma and COPD at higher risk of COVID-19.
Healthy habits that help decrease COVID-19 infection risk include exercising, eating well, getting enough sleep, smoking cessation (electronic cigarettes or vaping as well), and getting your yearly flu shot.
Blog last updated: March 26, 2020